Dublin, April 01, 2026 (GLOBE NEWSWIRE) -- The "Automated Cell Processing System Market: Industry Trends and Global Forecasts, Till 2035 - Distribution by Cell Therapy Processing Step, Scale of Operation, End User and Key Geographical Regions" has been added to ResearchAndMarkets.com's offering.
The global automated cell processing system market, currently valued at USD 220 million, is anticipated to expand at a CAGR of 16% during the forecast period. This press release delves into the market's dynamics, highlighting key segmentation parameters and growth trends.
Market Segmentation:
- Cell Therapy Processing Steps: Apheresis, Separation, Expansion, Harvest, Fill/Finish, Cryopreservation, Thawing
- Scale of Operation: Pre-clinical/Clinical Operations, Commercial Organizations
- End Users: Hospitals, Medical Centers, Clinics, Research Institutes, Academic Institutes, Cell Therapy Manufacturers/Developers
- Key Geographical Regions: North America, Europe, Asia-Pacific, Latin America, Middle East, and North Africa
Market Growth and Trends
Advances in biotechnology have increased cell therapy candidates, with over 2,000 currently being assessed for various diseases. Recognized for their potential in treating cancer, rare, and chronic diseases, cellular therapies are attracting substantial industry interest. Traditional cell therapy manufacturing is labor-intensive and costly, leading to increased demand for efficient solutions. Modern automated and closed systems are expected to significantly reduce production costs.
One prominent example is the GMP-In-A-Box, which enhances throughput, minimizes idle times, and reduces manual labor. Consequently, the cell processing systems market is set to realize lucrative growth.
Key Insights:
- Over 60 innovative automated systems have been developed, automating stages from development to cryopreservation.
- The market features both established players and new entrants focusing on novel technologies.
- Since 2010, numerous startups dedicated to automated systems have emerged, drawing interest from major industry players.
- Most systems align with regulatory standards, as seen in BATON and the volta loop.
- There has been a rise in partnerships, with a CAGR of 24% in this domain; 70% of such deals have materialized since 2018.
- Strategic partnerships present opportunities for integrating advanced features.
- The automated systems market is projected to grow at 16% annually over the next decade.
Prominent Market Players: AstraZeneca, Baxter, Bayer, Cytiva, Cellular Therapeutics, Lonza, Merck, Pall, Terumo BCT, ThermoGenesis.
Research Coverage and Insights:
- Detailed market sizing and opportunity analysis across segments.
- A thorough assessment of automated systems and their features.
- Competitive analysis focusing on supplier power and offerings.
- Company profiles with insights into finances, products, and future outlooks.
- Analysis of partnerships, focusing on key technologies and collaborators.
- Initiatives by major pharma players in the automated cell processing sector.
Key Questions Answered:
- What is the current company involvement in the market?
- Who are the market leaders?
- What factors influence market growth?
- What is the market size now and in the future?
- What is the market's CAGR?
- How are opportunities distributed among key segments?
Reasons to Buy:
- Comprehensive market analysis with revenue projections.
- Insights into competitive dynamics and strategic opportunities.
- Understanding of market drivers, barriers, and trends for decision-making.
For more information about this report visit https://www.researchandmarkets.com/r/3maqez
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
